Home › Funds › SR ONE CAPITAL MANAGEMENT, LP › NKTX
SR ONE CAPITAL MANAGEMENT, LP position in NKTX
NKARTA INC · Health Care
SR ONE CAPITAL MANAGEMENT, LP reported holding 3,333,333 shares of NKTX (NKARTA INC) in its Q2 2026 13F filing — a position valued at US$9.4M, representing 0.91% of its reported portfolio and ranking #12 among its reported holdings. SR ONE CAPITAL MANAGEMENT, LP has disclosed NKTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SR ONE CAPITAL MANAGEMENT, LP's NKTX position evolved
SR ONE CAPITAL MANAGEMENT, LP first disclosed a stake in NKTX in Q3 2023 at 1,333,333 shares (US$1.9M). The position peaked in Q1 2024 at 3,333,333 shares, worth US$36.0M. Across 12 filings, SR ONE CAPITAL MANAGEMENT, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 3,333,333 shares valued at US$9.4M. Notable position changes include a 150% increase in Q1 2024 (shares fell 45% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.33M | $1.85M | New |
| Q4 2023 | 1.33M | $8.80M | Hold |
| Q1 2024 | 3.33M | $36.03M | Add |
| Q2 2024 | 3.33M | $19.70M | Hold |
| Q3 2024 | 3.33M | $15.07M | Hold |
| Q4 2024 | 3.33M | $8.30M | Hold |
| Q1 2025 | 3.33M | $6.13M | Hold |
| Q2 2025 | 3.33M | $5.53M | Hold |
| Q3 2025 | 3.33M | $6.90M | Hold |
| Q4 2025 | 3.33M | $6.17M | Hold |
| Q1 2026 | 3.33M | $7.03M | Hold |
| Q2 2026 | 3.33M | $9.43M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NKTX and 13F data
NKTX (NKARTA INC) is a Health Care company. 28 other funds we track also report a position in NKTX — the largest reported positions include NEA Management Company, LLC (US$10.1M), Samsara BioCapital, LLC (US$9.9M), GSK plc (US$8.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NKTX
- NEA Management Company, LLC 3.57M sh · $10.10M · Q2 2026
- Samsara BioCapital, LLC 3.51M sh · $9.93M · Q2 2026
- GSK plc 3.15M sh · $8.92M · Q2 2026
- Monaco Asset Management SAM 2.37M sh · $6.72M · Q2 2026
- Peapod Lane Capital LLC 518.41K sh · $1.36M · Q3 2026
More on SR ONE CAPITAL MANAGEMENT, LP
FAQ
How long has SR ONE CAPITAL MANAGEMENT, LP held NKTX?
SR ONE CAPITAL MANAGEMENT, LP has disclosed NKTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is SR ONE CAPITAL MANAGEMENT, LP's current position in NKTX?
As of Q2 2026, SR ONE CAPITAL MANAGEMENT, LP holds 3.33M shares of NKTX (NKARTA INC), valued at $9.43M, representing 0.91% of its reported portfolio and ranking #12.
Has SR ONE CAPITAL MANAGEMENT, LP been buying or selling NKTX?
In the latest 13F filing (Q2 2026), SR ONE CAPITAL MANAGEMENT, LP held unchanged its position in NKTX. The position peaked in Q1 2024 at 3.33M shares.
Which other funds hold NKTX?
Other major institutional holders of NKTX include NEA Management Company, LLC, Samsara BioCapital, LLC, GSK plc, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.